Heron Therapeutics Inc at Needham Healthcare Conference (Virtual) Transcript
Hi, good morning. I'm Serge Belanger, one of the senior healthcare analysts at Needham. Want to welcome you to our 22nd Annual Healthcare Conference.
And for our next session, we're happy to have with us the new CEO of Heron Therapeutics, Craig Collard. He's going to give us an overview of the company, then we'll jump to Q&A. For those listening in on the conference portal, you do have the option to submit questions. It should be at the bottom of the screen you're currently looking at.
So, Craig, I'll hand it over to you. I know it's only been a few weeks in the new seat, but looking forward to speaking with you about Heron today.
Okay. Thanks, Serge. I'll really just give a brief overview of the company. Again, I've been here two weeks and came into this fairly fast [activist] group that came into the company. I joined originally as a Board member and wasn't really anticipating jumping right into the CEO role, and that became available.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
